Artículos por temáticas

The role of protein glycosylation in Alzheimer disease

Schedin-Weiss S, Winblad B, Tjernberg LO.

FEBS J. 2014 Jan;281(1):46-62. doi: 10.1111/febs.12590. Epub 2013 Nov 26.

Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease

Drolle E, Hane F, Lee B, Leonenko Z.

Drug Metab Rev. 2014 May;46(2):207-23. doi: 10.3109/03602532.2014.882354. Epub 2014 Feb 5.

Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2

Vandal M, Alata W, Tremblay C, Rioux-Perreault C, Salem N Jr, Calon F, Plourde M.

J Neurochem. 2014 May;129(3):516-26. doi: 10.1111/jnc.12640. Epub 2014 Jan 29.

Sleep and Alzheimer disease pathology--a bidirectional relationship

Ju YE, Lucey BP, Holtzman DM.

Nat Rev Neurol. 2014 Feb;10(2):115-9. doi: 10.1038/nrneurol.2013.269. Epub 2013 Dec 24.

An anemia of Alzheimer's disease

Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL; AIBL Research Group; Bush AI.

Mol Psychiatry. 2014 Nov;19(11):1227-34. doi: 10.1038/mp.2013.178. Epub 2014 Jan 14.

Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination

van Wijk N, Broersen LM, de Wilde MC, Hageman RJ, Groenendijk M, Sijben JW, Kamphuis PJ.

J Alzheimers Dis. 2014;38(3):459-79. doi: 10.3233/JAD-130998.

Evaluation of common structural brain changes in aging and Alzheimer disease with the use of an MRI-based brain atrophy and lesion index: a comparison between T1WI and T2WI at 1.5T and 3T

Guo H, Song X, Vandorpe R, Zhang Y, Chen W, Zhang N, Schmidt MH, Rockwood K; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2014 Mar;35(3):504-12. doi: 10.3174/ajnr.A3709. Epub 2013 Aug 29.

Smaller sized inhaled anesthetics have more potency on senescence-accelerated prone-8 mice compared with senescence-resistant-1 mice

Xu H, Lu B, Zheng B, Tian J, Qi B, Deng Y, He Z, Su D, Wang X.

J Alzheimers Dis. 2014;39(1):29-34. doi: 10.3233/JAD-130902.

Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies

Swomley AM, Förster S, Keeney JT, Triplett J, Zhang Z, Sultana R, Butterfield DA.

Biochim Biophys Acta. 2014 Aug;1842(8):1248-57. doi: 10.1016/j.bbadis.2013.09.015. Epub 2013 Oct 9.

A Novel Presenilin 1 Mutation in Early-Onset Alzheimer's Disease With Prominent Frontal Features

Nygaard HB, Lippa CF, Mehdi D, Baehring JM.

Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):433-5. doi: 10.1177/1533317513518653. Epub 2014 Jan 24.

Change in body mass index before and after Alzheimer's disease onset

Gu Y, Scarmeas N, Cosentino S, Brandt J, Albert M, Blacker D, Dubois B, Stern Y.

Curr Alzheimer Res. 2014 May;11(4):349-56. doi: 10.2174/1567205010666131120110930.

Vision function abnormalities in Alzheimer disease

Tzekov R, Mullan M.

Surv Ophthalmol. 2014 Jul-Aug;59(4):414-33. doi: 10.1016/j.survophthal.2013.10.002. Epub 2013 Oct 22.

The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease: a meta-analysis

Wei W, Xu X, Li H, Zhang Y, Han D, Wang Y, Yan W, Wang X, Zhang J, Liu N, You Y.

Neuromolecular Med. 2014 Jun;16(2):448-56. doi: 10.1007/s12017-014-8291-0. Epub 2014 Feb 5.

[Visual impairment in posterior cortical atrophy--visual variant of Alzheimer's disease in the ophthalmic practice]

Barczak A, Sitek EJ, Chudoba T.

Klin Oczna. 2014;116(3):215-8.

CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility

Raj T, Ryan KJ, Replogle JM, Chibnik LB, Rosenkrantz L, Tang A, Rothamel K, Stranger BE, Bennett DA, Evans DA, De Jager PL, Bradshaw EM.

Hum Mol Genet. 2014 May 15;23(10):2729-36. doi: 10.1093/hmg/ddt666. Epub 2013 Dec 30.